Efficacy and Mechanisms of Energy Medicine to Decrease Chronic Knee Pain in Outpatient Settings
Status: | Not yet recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 70 |
Updated: | 1/30/2019 |
Start Date: | June 30, 2019 |
End Date: | December 2019 |
This study will assess the efficacy and mechanisms behind Energy Medicine in reducing chronic
knee pain within an outpatient setting. This study will investigate a form of Energy Medicine
(EM) performed by a natural solo practitioner, using a standard number of three sessions,
which will compare to both positive and negative control groups. The positive control group
will receive acupuncture and the negative control group will receive a sham intervention.
knee pain within an outpatient setting. This study will investigate a form of Energy Medicine
(EM) performed by a natural solo practitioner, using a standard number of three sessions,
which will compare to both positive and negative control groups. The positive control group
will receive acupuncture and the negative control group will receive a sham intervention.
Inclusion Criteria:
- Presence of knee pain lasting for at least six months
- No radiation of knee pain
- No acupuncture treatments in the previous six months
- Failure to respond completely to the medications given by their orthopedic or pain
management specialist
- Knee pain on most days (4 out of 7 days of the week) with average self-reported
severity of 4 or more out of 10 on a numeric rating scale (NRS)
- Complaints of morning stiffness lasting less than 30 minutes
- Not be in active physical therapy (PT) for the duration of the trial.
- Adult patients ≥18 years of age
- English speaking
Exclusion Criteria:
- Any concurrent diagnosis of systemic disease
- Other concurrent treatments such as massage, Acupcunture, PT or any kind of Energy
Medicine
- Bleeding disorder
- Trypanophobia (fear of needles or injections).
- Have medical condition that causes difficulty in saliva production/collection (i.e.:
Sjogren's Syndrome)
We found this trial at
1
site
462 1st Avenue
New York, New York 10010
New York, New York 10010
Principal Investigator: Barbara Siminovich-blok, MD
Phone: 212-263-4919
Click here to add this to my saved trials